Notably, in our prior work utilizing primarily PDAC mouse models with advanced metastatic disease, CTCs shared expression of ECM associated genes including FN1 and SPARC10,11, implying multiple potential drivers of these pro-metastatic markers. The gene discussed is MMRN1; the disease is metastatic neoplasm.